infanrix- ipv preservative free
pertactin; diphtheria toxoid; pertussis toxoid; poliovirus; tetanus toxoid; pertussis filamentous haemagglutinin -
infanrix-hexa
tetanus toxoid; diphtheria toxoid; polyribose ribitol phosphate - haemophilus influenzae type b; poliovirus; pertactin; pertussis toxoid; hepatitis b surface antigen recombinant; pertussis filamentous haemagglutinin -
hexaxim
sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, pertussis toxoid/filamentous haemagglutinin, poliovirus types 1/2/3, hepatitis b surface antigen, haemophilus infuenzae type b polysaccharide, haemophilus infuenzae type b polysaccharide conjugated to tetanus protein - suspension for injection - 20iu/0.5ml+40iu/0.5ml+25/25mcg/0.5ml+40/8/32 du/0.5ml+10mcg/0.5ml+12mcg/0.5ml+22-36mcg/0.5ml
hexaxim
sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, pertussis toxoid/filamentous haemagglutinin, poliovirus types 1/2/3, hepatitis b surface antigen, haemophilus infuenzae type b polysaccharide, haemophilus infuenzae type b polysaccharide conjugated to tetanus protein - suspension for injection - 20iu/0.5ml+40iu/0.5ml+25/25mcg/0.5ml+40/8/32 du/0.5ml+10mcg/0.5ml+12mcg/0.5ml+22-36mcg/0.5ml
hexaxim suspension for injection
sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, pertussis toxoid/filamentous haemagglutinin, poliovirus types 1/2/3, hepatitis b surface antigen, haemophilus infuenzae type b polysaccharide, haemophilus infuenzae type b polysaccharide conjugated to tetanus protein - suspension for injection - 20iu/0.5ml+ 40iu/0.5ml+ 25/25mcg/0.5ml+ 40/8/32 du/0.5ml+ 10mcg/0.5ml+ 12mcg/0.5ml+ 22-36mcg/0.5ml
hexaxim suspension for injection
sanofi pasteur sa - diphtheria toxoid, tetanus toxoid, pertussis toxoid/filamentous haemagglutinin, poliovirus types 1/2/3, hepatitis b surface antigen, haemophilus infuenzae type b polysaccharide, haemophilus infuenzae type b polysaccharide conjugated to tetanus protein - suspension for injection - 20iu/0.5ml+ 40iu/0.5ml+ 25/25mcg/0.5ml+ 40/8/32 du/0.5ml+ 10mcg/0.5ml+ 12mcg/0.5ml+ 22-36mcg/0.5ml
infanrix-penta
glaxosmithkline nz limited - diphtheria toxoid, adsorbed 30 [iu]; hepatitis b surface antigen, recombinant 10ug; pertactin 8ug; pertussis filamentous haemagglutinin 25ug; pertussis toxoid, adsorbed 25ug; polio virus type 1 40 dagu (/dose); polio virus type 2 8 dagu (/dose); polio virus type 3 32 dagu (/dose); tetanus toxoid, adsorbed 40 [iu] - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 30 [iu] hepatitis b surface antigen, recombinant 10ug pertactin 8ug pertussis filamentous haemagglutinin 25ug pertussis toxoid, adsorbed 25ug polio virus type 1 40 dagu (/dose) polio virus type 2 8 dagu (/dose) polio virus type 3 32 dagu (/dose) tetanus toxoid, adsorbed 40 [iu] excipient: aluminium hydroxide aluminium phosphate formaldehyde glycine medium 199 monobasic potassium phosphate neomycin sulfate polymyxin b sulfate polysorbate 20 potassium chloride sodium chloride sodium phosphate (32p) water for injection - infanrix®-penta is indicated for immunisation against diphtheria, tetanus, pertussis, hepatitis b and poliomyelitis in infants from the age of 6 weeks and may also be given to infants who received a first dose of hepatitis b vaccine at birth.
infanrix hexa vaccine
glaxosmithkline pharmaceutical sdn. bhd. - diphtheria toxoid; tetanus toxoid; pertussis toxoid (pt); haemophilus influenza type b conjugate to; pertactin (69 kda outer membrane protein-69k); inactivated polio virus type 3; inactivated polio virus type 2; inactivated polio virus type 1; filamentous haemagglutinin (fha); r-dna hepatitis b antigen -
hexaxim suspension for injection in pre-filled syringe
sanofi-aventis singapore pte. ltd. - diphtheria toxoid; filamentous haemagglutinin; haemophilus influenza type b polysaccharide (polyribosylribitol phosphate) conjugated to 22 - 36 μg tetanus protein (prp-t); hepatitis b surface antigen; pertussis toxoid; poliovirius (inactivated) type 1 (mahoney); poliovirus (inactivated) type 2 (mef-1); poliovirus (inactivated) type 3 (saukett); tetanus toxoid - injection, suspension - diphtheria toxoid 30 lf (>= 20 iu)/0.5 ml; filamentous haemagglutinin 25 μg/0.5 ml; haemophilus influenza type b polysaccharide (polyribosylribitol phosphate) conjugated to 22 - 36 μg tetanus protein (prp-t) 12 μg/0.5 ml; hepatitis b surface antigen 10 μg/0.5 ml; pertussis toxoid 25 μg/0.5 ml; poliovirius (inactivated) type 1 (mahoney) 40 du/0.5 ml; poliovirus (inactivated) type 2 (mef-1) 8 du/0.5 ml; poliovirus (inactivated) type 3 (saukett) 32 du/0.5 ml; tetanus toxoid 10 lf (>= 40 iu)/0.5 ml
infanrix-ipv+hib
glaxosmithkline nz limited - diphtheria toxoid, adsorbed 30 [iu] (not less than); pertactin 8ug; pertussis filamentous haemagglutinin 25ug; pertussis toxoid, adsorbed 25ug; polio virus type 1 40 dagu (inactivated); polio virus type 2 8 dagu (inactivated); polio virus type 3 32 dagu (inactivated); tetanus toxoid, adsorbed 40 [iu] (not less than); haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (20 - 40 mcg of tetanus toxoid per dose) - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 30 [iu] (not less than) pertactin 8ug pertussis filamentous haemagglutinin 25ug pertussis toxoid, adsorbed 25ug polio virus type 1 40 dagu (inactivated) polio virus type 2 8 dagu (inactivated) polio virus type 3 32 dagu (inactivated) tetanus toxoid, adsorbed 40 [iu] (not less than) excipient: aluminium lactose medium 199 sodium chloride water for injection active: haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (20 - 40 mcg of tetanus toxoid per dose) - infanrix??-ipv+hib is indicated as a booster dose for children aged 15 months and older who have previously been immunised with dtp, polio and hib antigens. the hib component of the vaccine does not protect against diseases due to other serotypes of haemophilus influenzae nor against meningitis caused by other organisms.